Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2021-02-19
2024-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 Epidemic Response Study
NCT04357496
Recovery of Respiratory System in COVID-19 Patients
NCT04954222
Long-Term Experience and Health Effects of COVID-19
NCT04477902
Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus
NCT04292327
Understanding COVID-19
NCT04329546
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID-19 Patients
Subjects who have recovered from COVID-19
No Intervention Used
There is no intervention in this study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Intervention Used
There is no intervention in this study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Male or female of 18 years of age or older
3. Diagnosis of COVID-19 infection by RT- PCR
4. Recovery from COVID-19
18 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ProgenaBiome
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sabine Hazan, MD
Role: STUDY_DIRECTOR
ProgenaBiome
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ginger Aurella
Ventura, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRG-051
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.